On the heels of the first pulsed-field ablation device to win approval for atrial fibrillation ablation, a novel version of ...

IRVINE, Calif., April 25, 2025 /PRNewswire/ -- Johnson & Johnson MedTech, a global leader in cardiac arrhythmia treatment, today announced positive, initial 3-month results from the Omny-IRE study ...

IRVINE, Calif., April 25, 2025 /PRNewswire/ -- Johnson & Johnson MedTech, a global leader in cardiac arrhythmia treatment, today announced positive, initial 3-month results from the Omny-IRE study ...

Johnson & Johnson shares are down 3% Wednesday on safety concerns that could dim sales prospects for a new heart device, while its rivals gained. J&J said it temporarily paused the use of the ...

Johnson & Johnson is set to release first-quarter results on Tuesday before the market opens. Here is what you need to know. PROFIT: The healthcare conglomerate is expected to post a profit of $5. ...

Johnson & Johnson MedTech is also supporting the presentation of real-world evidence data from the company sponsored REAL AF Registry, a database comprised of 68 centers investigating real-world ...

Investing.com -- Johnson & Johnson (NYSE: JNJ) announced on Friday that it is set to recommence the limited market release of its VARIPULSE™ devices in the United States. The decision comes after an ...